| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.14B | 27.01B | 28.93B | 27.07B | 31.88B | 36.01B |
| Gross Profit | 9.44B | 10.38B | 12.08B | 11.28B | 13.82B | 14.68B |
| EBITDA | 2.30B | 3.14B | 4.58B | 3.14B | 4.17B | 6.64B |
| Net Income | 1.19B | 1.29B | 2.21B | 1.84B | 2.45B | 2.77B |
Balance Sheet | ||||||
| Total Assets | 16.37B | 14.90B | 14.54B | 16.82B | 17.80B | 17.71B |
| Cash, Cash Equivalents and Short-Term Investments | 5.65B | 2.59B | 1.96B | 2.38B | 1.75B | 1.23B |
| Total Debt | 5.72B | 4.06B | 2.71B | 4.21B | 3.57B | 4.99B |
| Total Liabilities | 7.40B | 5.84B | 4.69B | 6.99B | 7.21B | 8.00B |
| Stockholders Equity | 8.97B | 9.06B | 9.85B | 9.83B | 10.58B | 9.71B |
Cash Flow | ||||||
| Free Cash Flow | 2.17B | 3.38B | 2.73B | 3.99B | 4.97B | 4.06B |
| Operating Cash Flow | 2.50B | 3.76B | 3.13B | 4.35B | 5.69B | 4.71B |
| Investing Cash Flow | -309.10M | -297.50M | -198.10M | -305.60M | -671.30M | 2.10B |
| Financing Cash Flow | -2.50B | -2.83B | -3.33B | -3.44B | -4.49B | -8.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | HK$4.28B | 11.87 | 8.63% | 4.83% | -7.34% | -28.66% | |
69 Neutral | HK$12.26B | 9.54 | 9.08% | 4.94% | -12.29% | 21.00% | |
68 Neutral | HK$16.99B | 5.77 | 13.24% | 9.65% | -5.66% | -31.36% | |
62 Neutral | HK$2.38B | 10.65 | 10.57% | 9.18% | 3.78% | -21.19% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
43 Neutral | HK$229.30M | 3.33 | ― | ― | ― | ― | |
42 Neutral | HK$4.16B | -44.65 | -5.51% | 0.32% | 1.21% | -5.68% |